In Final Guidance On Residual Solvents, FDA Allows Control, Not Just Testing, Verification
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency accepts industry comments on testing issue, but document may still contain hurdles for approval of some generic drugs.